[Pre- and postoperative chemotherapy for lung carcinoma].
The role of pre- and postoperative chemotherapy has been evaluated in non-small cell lung carcinoma, in particular locally advanced carcinomas. It has been stated in numerous reports that in stage IIIA, so-called N2 lung carcinoma, patients who receive induction chemotherapy have better survival rates compared with those who do not. In the expectation that postoperative survival could be prolonged in patients with stage IB and II lung cancer, various controlled trials have been performed in many countries, including Japan. Currently, induction chemoradiotherapy for stage III disease is being evaluated worldwide.